Allianz Asset Management
PRCT icon

Allianz Asset Management’s Procept Biorobotics PRCT Stock Holding History

Allianz Asset Management’s Portfolio PRCT Stock Details PRCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-77,636
Closed -$4.47M – 2072
2025
Q2 		$4.47M Sell
77,636
-31,315
-29% -$1.77M 0.01% 1161
2025
Q1 		$6.35M Buy
108,951
+837
+0.8% +$57.1K 0.01% 987
2024
Q4 		$8.71M Buy
108,114
+17,995
+20% +$1.54M 0.01% 797
2024
Q3 		$7.22M Buy
90,119
+4,213
+5% +$299K 0.01% 871
2024
Q2 		$5.25M Sell
85,906
-978
-1% -$58.2K 0.01% 940
2024
Q1 		$4.29M Sell
86,884
-9,751
-10% -$464K 0.01% 924
2023
Q4 		$4.05M Buy
96,635
+28,999
+43% +$987K 0.01% 1025
2023
Q3 		$2.22M Sell
67,636
-2,611
-4% -$89K ﹤0.01% 1391
2023
Q2 		$2.48K Buy
70,247
+10,212
+17% +$338K ﹤0.01% 2009
2023
Q1 		$1.7M Buy
+60,035
New +$2.12M ﹤0.01% 1448

Other funds holding PRCT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $3.71B AUM 19.51% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Allianz Asset Management's PRCT Position: Q3 2025 in Review

Allianz Asset Management sold out of Procept Biorobotics (PRCT) in Q3 2025, closing a stake of 77,636 shares — an estimated $4.47M sold.

Allianz Asset Management first reported a position in PRCT in Q1 2023 and held it in 10 quarters. The position peaked at $8.71M in Q4 2024. 242 funds tracked by Wall St. Rank hold PRCT as of Q3 2025.

  • Allianz Asset Management reported no remaining Procept Biorobotics position as of Q3 2025 after selling out during the quarter.
  • Allianz Asset Management sold 77,636 Procept Biorobotics shares in Q3 2025, an estimated $4.47M.
  • Allianz Asset Management first reported a position in Procept Biorobotics in Q1 2023 and held it in 10 quarters.
  • Allianz Asset Management's Procept Biorobotics position peaked at $8.71M in Q4 2024.
  • 242 funds tracked by Wall St. Rank held Procept Biorobotics as of Q3 2025.

Based on Allianz Asset Management's 13F filing for Q3 2025, filed 4 Nov 2025.